Greenbis Labs

(Biotechnology, Medicine and Health)

Introduction

Greenbis Labs S.L. activity is based on the import, certification and primary reconditioning of high quality Cannabis sativa flower for medical and scientific uses, as well as the manufacture of extracts derived under European regulations EU-GMP.
Our laboratory offers a service of analysis, stability studies and GMP certification to producers of raw materials who wish to distribute their product and introduce it on the European market with all legal and quality guarantees.

Greenbis Labs

Technology offer

Technical Specifications
  • Technology partner: IMP Research and Distribution S.L.U
  • Business model: Reconditioning, reclassification and release of cannabis flower as a medicine for direct patient prescription or distribution to pharmacy offices.
  • Digital marketing
  • Other
Benefits of Technology
  • Innovative aspects: The company offers new models of primary packaging and storage for cannabinoid-based medicines.
  • Competitive advantages: Stability studies and ad hoc conditioning models for different cannabis chemotypes.
Technology Applications
  • New models of therapeutic guidelines for patients whose treatments make use of medical cannabis under prescription.
Sectors to which company is directed
  • Pharmaceutical industry

Team

Pablo González Arroyo

CEO

Teresa García Cervera

Pharmaceutical Technical Director

Contact information

Pablo González ArroyoCEOgerencia@greenbislabs.comMobile Phone: +34 637 53 15 50
www.grenbislabs.com